B6.129P2-B2mtm1Unc/Orl

Status

Available to order

EMMA IDEM:00029
International strain nameB6.129P2-B2mtm1Unc/Orl
Alternative namebeta2m°
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolB2mtm1Unc
Gene/Transgene symbolB2m

Information from provider

ProviderBeverly H. Koller
Provider affiliationc/o CDTA-Orleans
Phenotypic informationThe B2M protein is linked to MHC class I molecules. The mutant mice carry a null mutation in the beta-2 microglobulin (B2m) gene. Obtained by mutation of the B2m gene by homologous recombination (insertion of neomycin-resistance gene). Class I molecules are lacking or unstable on the cell surface, leading to a nearly elimination of the T CD8+ compartment. Cytotoxic immune responses are much altered.
Breeding history129P2/OlaHsd ES cells; 9 generations of backcross to C57BL/6, then intercross.
References
  • Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.;Koller B H, Marrack P, Kappler J W, Smithies O, ;1990;Science (New York, N.Y.);248;1227-30; 2112266

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • preweaning lethality, incomplete penetrance / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • small superior vagus ganglion / IMPC
  • embryonic lethality prior to tooth bud stage / IMPC
  • abnormal skin morphology / IMPC
  • hydrometra / IMPC
  • increased circulating phosphate level / IMPC
MGI phenotypes (allele matching)
  • decreased level of surface class I molecules / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • decreased IgG level / MGI
  • abnormal pancreas morphology / MGI
  • decreased susceptibility to bacterial infection / MGI
  • increased IgM level / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • decreased circulating serum albumin level / MGI
  • increased T-helper 1 cell number / MGI
  • abnormal interleukin level / MGI
  • abnormal tumor necrosis factor level / MGI
  • increased susceptibility to infection induced morbidity/mortality / MGI
  • absent CD8-positive, alpha-beta T cells / MGI
  • abnormal pancreatic beta cell morphology / MGI
  • abnormal T cell number / MGI
  • insulitis / MGI
MGI phenotypes (gene matching)
  • absent CD8-positive, alpha-beta T cells / MGI
  • decreased IgG level / MGI
  • decreased level of surface class I molecules / MGI
  • abnormal pancreas morphology / MGI
  • decreased susceptibility to bacterial infection / MGI
  • abnormal CD8-positive, alpha-beta cytotoxic T cell morphology / MGI
  • increased IgM level / MGI
  • insulitis / MGI
  • abnormal lateral geniculate nucleus morphology / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • decreased susceptibility to parasitic infection / MGI
  • abnormal cytotoxic T cell physiology / MGI
  • abnormal pancreatic beta cell morphology / MGI
  • decreased circulating serum albumin level / MGI
  • hemochromatosis / MGI
  • abnormal T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • increased T-helper 1 cell number / MGI
  • increased gamma-delta T cell number / MGI
  • increased gamma-delta intraepithelial T cell number / MGI
  • increased tumor necrosis factor secretion / MGI
  • increased interleukin-3 secretion / MGI
  • decreased interleukin-4 secretion / MGI
  • abnormal interleukin level / MGI
  • abnormal tumor necrosis factor level / MGI
  • increased susceptibility to infection induced morbidity/mortality / MGI

Literature references

  • Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.;Koller B H, Marrack P, Kappler J W, Smithies O, ;1990;Science (New York, N.Y.);248;1227-30; 2112266

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).